Just a few days after FDA Commissioner Makary resigned, ally Tracy Beth Høeg is also leaving the agency. Her departure comes ...
Rina-S is the last candidate standing from Genmab’s $1.8 billion ProfoundBio acquisition two years ago, with the Danish drugmaker ending development of another clinical program stemming from the ...
Shares of REGENXBIO declined 37% on a mixed data readout and other updates from the company's first quarter earnings call ...
Renewed pharma interest in GPCR biology and radioligand therapies is drawing attention to functional peptide screening ...
In a letter to President Donald Trump, a group of biotech executives recommended former cancer regulator Richard Pazdur to ...
While Biogen’s tau-targeting therapy didn’t demonstrate improvement on a dementia severity scale, the company touted ...
Degron Therapeutics will have stiff competition in immunology, as Novartis inked a $5.7 billion agreement with Monte Rosa ...
The FDA has cleared BeOne Medicines’ BCL2 blocker sonrotoclax for the treatment of certain patients with mantle cell lymphoma ...
While Takeda is eliminating 4,500 roles across its global operations, the company has some 2,200 jobs currently open for hiring, for which internal candidates will be prioritized. In an effort to cut ...
Looking for a biopharma job in California? Check out the BioSpace list of 17 companies hiring life sciences professionals like you. If you’re interested in working at a pharma or biotech in California ...
After a 12-month period that saw the Belgian biotech consider a spinout, swap out CEOs, and enter a three-way acquisition ...
Three pharma CEOs joined the $30 million compensation club in 2025 but Eli Lilly’s David Ricks exceeded his nearest peer by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results